Trade Summary

3 days ago, OYLER JOHN, serving as Chief Executive Officer at BeOne Medicines Ltd. (ONC), sold 4,940 shares at $270.56 per share, for a total transaction value of $1,336,547.59.

This sale represents a 100.00% decrease in OYLER JOHN's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, June 8, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, June 10, 2026 at 5:22 PM ET, 2 days after the trade was made.

BeOne Medicines Ltd. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.